Cagrilintide is a long-acting amylin analogue engineered from modifications to human amylin peptide sequences to improve stability and receptor activity in vivo. It has been studied in metabolic research for its relationship to satiety signaling, gastric emptying behavior, energy intake, and glucoregulatory pathways in combination and monotherapy settings. Its structure incorporates targeted amino acid substitutions and lipidation strategies that extend circulating half-life while preserving activity at amylin receptor complexes. Lyophilized powder, 3mL vial. Sold at 10mg per vial. For research use only.
